At Keensight Capital,
we grow together.

Sector experts.
Partners in growth.

Keensight Capital is a European Growth Buyout investor with deep expertise in Technology and Healthcare. We partner with the management teams of fast growing and profitable companies providing capital, strategic guidance and operational support.

About us

Latest activities

Latest news

Keensight Capital is certified Great Place to Work®ESGNews

Keensight Capital is certified Great Place to Work®

February 4, 2026
Keensight Capital appoints Julian Bennet as Managing DirectorPress Release

Keensight Capital appoints Julian Bennet as Managing Director

January 20, 2026
inherent group announces acquisition of Inovacom, a managed IT, cloud and telecommunications services providerPress Release

inherent group announces acquisition of Inovacom, a managed IT, cloud and telecommunications services provider

January 13, 2026
Keensight Capital announces 2026 leadership promotionsNews

Keensight Capital announces 2026 leadership promotions

January 8, 2026

Latest deals

Bedfont Scientific

Bedfont Scientific

Leader in non-invasive breath analysis medical devices

Decision Focus

Decision Focus

Leading global software developer of Governance, Risk and Compliance (GRC) solutions

Isto Biologics

Isto Biologics

Leading orthobiologics and regenerative MedTech company

Uve

Uve

Data management and analytics software provider focused on the Consumer-Packaged Goods industry

Our CEOs talk about Keensight Capital

Stories

Key figures

25+ 
years of experience in Technology and Healthcare

7bn€
assets under management as of September 30, 2025

28
nationalities in the team

10-800m€ 
investment tickets

39% 
IRR from a total of 51 exited investments

18% 
average annual portfolio revenue growth over the past 5 years